… is an independent predictor of both cancer volume and pathological stage. This relationship
does not exist for MCCL from a NTB core. … patients with prostate cancer before treatment. …

… (MRI)-targeted prostate biopsy is not well defined. We aimed … significant prostate cancer
included any biopsy core assigned … To determine an individual biopsy core’s distance from the …

… biopsy cores to obtain from a region of interest to maximize detection of clinically significant
prostate cancer. … The length of each biopsy core and the percentage of each core comprised …

… -guided prostate biopsy leads to increasing detection rates of … The systematically obtained
cancer-positive biopsy core within this … Underestimation of tumor size in mpMRI images was …

… biopsies increased the percentage of positive cores and detection of clinically significant
prostate cancers; … Additional cores may be considered based on the lesion size and location, …

… biopsies reduces the number of cores required and can … for detecting csPCa than a systematic
TRUS biopsy first … relate to variables such as prostate size, lesion characteristics, operator …

… the diagnostic yield of prostate cancer per biopsy core. Not … of PB-mpMRI, it is necessary to
investigate the effects of its … number of involved cores or the maximum PCa core length in the …

… assess the impact of MRI characteristics (score, size, number … terms of clinically significant
prostate cancer detection by high-… We used a standard transrectal route for all prostate biopsies…

… the increase in detection of clinically significant cancer in the prostate when the number
of … between the size or location of tumor to incremental biopsy yield of clinically significant …

… cancers detected through sampling of five or fewer cores, … of cores obtained from a single
ROI impacts diagnostic yield … compared with total cores was not different for prostate size <40 …